Portfolio
The Star Hi Herbs IP portfolio.
41
Patent filings
5
PCT applications
5
Territories filed
4
Granted-patent platforms
Filings span India, the United States, Europe, Japan and Korea, together with PCT applications. Granted patents include Indian patents for TurmiMax® and Forcslim™, a granted US patent associated with Bacosane®, and granted patents within the Storg® platform.
Documented
What protects Bacospore®.
- Strain identity: Heyndrickxia coagulans MTCC 25308, also referenced as ATCC PTA-126364, deposited in two international culture collections.
- Controlled production: Proprietary fermentation know-how, standardized by viable spore count at a dedicated in-house facility.
- Registered trademark: The Bacospore® mark, licensed to qualifying finished-product manufacturers under a written agreement.
- Commercial potency: Bacospore® 300B specifies not less than 300 billion viable spores per gram.
- Strain-specific research: Gastroprotective, antidiarrheal, anti-collagenase and cholesterol-lowering activities, published in two peer-reviewed papers.
For patent detail relevant to your market and product format, contact the Star Hi Herbs IP team.
Notice
Territory and claim scope.
Patent rights are jurisdiction-specific and vary according to formulation, dosage form, application, health claim and intended market. Our IP team confirms the position for your territory and product before you manufacture, market or make claims for a finished product.